Melatonin and Radiation Therapy in Treating Patients With Brain Metastases

Completed · Phase 2

Conditions studied: Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as melatonin may make tumor cells more sensitive to radiation therapy and may protect normal cells from the side effects of radiation therapy. PURPOSE: Randomized phase II trial to determine the effectiveness of combining melatonin with radiation therapy in treating patients who have brain metastases.

Key facts

Study ID
NCT00031967
Run by
Radiation Therapy Oncology Group
Starts
2002-05-01
Last updated by the study team
2020-10-22

Who can join

Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.